| ACAN | Aggrecan |
| ACI | Autologous chondrocyte implantation |
| ACL | Anterior cruciate ligament |
| ACLT | Anterior cruciate ligament transection |
| ADAMTS | A disintegrin and metalloproteinase with thrombospondin motifs |
| AI | Artificial intelligence |
| ARGS | Alanine–Arginine–Glycine–Serine |
| BMI | Body mass index |
| C1,2C | Type I/II collagen degradation |
| C2C | Type II collagen cleavage product |
| C2M | MMP-mediated type II collagen |
| CCL2 | CC-chemokine ligand 2, also known as MCP-1 |
| CH | Chondrocyte |
| CHI3L1 | Chitinase 3-like 1 |
| CLU | Clusterin |
| COLI | Collagen I |
| COLII | Collagen II |
| COMP | Cartilage oligomeric matrix protein |
| CPII | Procollagen II c-propeptide |
| CRP | C-reactive protein |
| CS | Chondroitin sulphate |
| CTX-I | C-terminal crosslinked telopeptide type I collagen |
| CTX-II | C-terminal crosslinked telopeptide type II collagen |
| CXCL | Chemokine ligand |
| DAMPs | Damage-associated molecular patterns |
| ECM | Extracellular matrix |
| FB | Factor B |
| FRI | Fluorescence reflectance imaging |
| gp 130 | Glycol–protein 130 |
| HMGB1 | High mobility group box 1 |
| IFN-γ | Interferon gamma |
| IL | Interleukin |
| IL-1ra | IL-1 receptor antagonist |
| IL-6R | IL-6 receptor |
| iNOS | Inducible NO synthase |
| KOOS4 | Knee Injury and Osteoarthritis Outcome Score 4 |
| LIF | Leukemia inhibitor factor |
| LPS | Lipopolysaccharide |
| MASP | MBL-associated serine proteases |
| MBL | Mannose binding lectin |
| MCL | Medial collateral ligament |
| MSC | Mesenchymal stem cells |
| MCP-1 | Monocyte chemoattractant protein-1, also known as CCL2 |
| MIP-1β | Macrophage inflammatory protein-1 beta, also known as CCL4 |
| MIP-3α | Macrophage inflammatory protein-3 alpha, also known as CCL20 |
| MMPs | Matrix metalloproteinases |
| MMX | Partial medial meniscectomy |
| MNC | Mononuclear cells |
| MRI | Magnetic resonance imaging |
| NLRP3 | Nucleotide-binding oligomerization domain-like receptor pyrin domain-containing-3 |
| NO | Nitric oxide |
| NTX-1 | N-terminal telopeptides of type I collagen |
| OA | Osteoarthritis |
| OCL | Osteocalcin |
| OPN | Osteopontin |
| PG | Proteoglycan |
| PLGA | Poly (lactic-co-glycolic acid) |
| PPA | Pyrophosphate arthritis, also known as pseudogout |
| PRP | Platelet rich plasma |
| PRR | Pattern-recognition receptors |
| PTOA | Post-traumatic osteoarthritis |
| RA | Rheumatoid arthritis |
| SASP | Senescence-associated secretory phenotype |
| SCSO | Superficial zone chondrocytes |
| SF | Synovial fluid |
| sGAG | Sulfated glycosaminoglycan |
| SPARC | Secreted protein acidic and rich in cysteine, also known as osteonectin |
| sTCC | Soluble terminal complement complex |
| SnCs | Senescent cells |
| TIMP | Tissue inhibitor of metalloproteinases |
| TLRs | Toll-like receptors |
| TNF-α | Tumor necrosis factor alpha |
| TSG-6 | Product of tumor necrosis factor alpha-stimulated gene 6 |
| Th17 | T helper 17 |
| VEGF | Vascular endothelial growth factor |